American Portfolios Advisors Axsome Therapeutics, Inc. Transaction History
American Portfolios Advisors
- $2.36 Trillion
- Q3 2022
A detailed history of American Portfolios Advisors transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 110 shares of AXSM stock, worth $9,883. This represents 0.0% of its overall portfolio holdings.
Number of Shares
110Holding current value
$9,883% of portfolio
0.0%Shares
8 transactions
Others Institutions Holding AXSM
# of Institutions
288Shares Held
40.4MCall Options Held
365KPut Options Held
428K-
Rtw Investments, LP New York, NY4.63MShares$416 Million6.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.74MShares$336 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$297 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$212 Million37.71% of portfolio
-
Deep Track Capital, LP Greenwich, CT1.85MShares$166 Million4.89% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $3.85B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...